Positron emission tomography (PET) is getting ready to venture outside oncology, cardiology and mainstream neurology ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
Efficiency and effectiveness are inseparable in clinical medicine. Digital PET addresses them both. The key is the ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
October 24, 2018 — While liver biopsies are powerful and reliable, they are also invasive, painful, limited and subject ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
October 10, 2018 — The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI) at the University of ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
PET/CT can be indispensible as a diagnostic and prognostic tool; in the assessment of patient response to therapy and ...
September 27, 2018 — Advancements in healthcare technology, particularly in the surgery category, have led to an ...
September 26, 2018 — Bruker recently announced the introduction of the new preclinical PET/CT Si78 scanner for whole ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
September 5, 2018 — Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced a Phase 3 study of positron emission ...
August 24, 2018 — In a small study of military personnel who had suffered head trauma and had reported memory and mood ...
August 9, 2018 — In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
August 3, 2018 — Researchers have discovered a new nuclear medicine test that could improve care of patients with type 1 ...
July 17, 2018 — A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new ...
July 16, 2018 — At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 ...
June 29, 2018 — In the battle against metastatic castrate-resistant prostate cancer, studies have demonstrated a high ...
June 28, 2018 — At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, June 23-26, in ...
June 25, 2018 — IMV, part of the Science and Medicine Group and a market research and business intelligence provider to ...
June 21, 2018 — Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system ...
June 13, 2018 — A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron ...